A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

Summary

This 6-week study is to determine if the study drug, Methylphenidate Hydrochloride (HCl) Extended-Release Chewable Tablets (ERCT), is safe, tolerable and effective when compared to a sugar pill or placebo in children 4 to 5 years of age with ADHD.

Timeline

Start

2018-09-19

Primary completion

2021-04-22

Completion

2021-04-22

Outcome

Outcome not reported

Stopped (Enrollment): “The study was cancelled prior to the enrollment of any participants.”

Drugs

Indications